(1)
Safety and Effectiveness of New Embolization Microspheres SCBRM for Intermediate-Stage Hepatocellular Carcinoma: A Feasibility Study. Biomol Biomed 2021, 21 (3), 339-345. https://doi.org/10.17305/bjbms.2020.4770.